Drug
Maolactin
Maolactin: highest development phase Phase 3, developed by RDC Clinical Pty Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- RDC Clinical Pty Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| Maolactin NCT06444763 | Phase 3 | Chronic Inflammation |
Latest
No recent events.
Follow Maolactin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.